Genetic Technologies (GENE) - Shares outstanding

Number of shares outstanding as of December 2024 : 3,379,358

According to Genetic Technologies's latest financial reports and stock price the company's current number of shares outstanding is 3,379,358. At the end of 2008 the company had 135,444 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Genetic Technologies from 2004 to 2008

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2008	0.13 M	0%
2007	0.13 M	0%
2006	0.13 M	-0%
2005	0.13 M	21.75%
2004	0.11 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Eterna Therapeutics ERNA	5,410,000	60.09%	🇺🇸 USA
Myriad Genetics MYGN	90,900,000	2,589.86%	🇺🇸 USA
LabCorp LH	84,000,000	2,385.68%	🇺🇸 USA
Quest Diagnostics DGX	112,000,000	3,214.24%	🇺🇸 USA
Compugen CGEN	89,535,679	2,549.49%	🇮🇱 Israel
Danaher DHR	723,000,000	21,294.60%	🇺🇸 USA
Thermo Fisher Scientific TMO	382,000,000	11,203.92%	🇺🇸 USA
Neogen NEOG	216,695,348	6,312.32%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Genetic Technologies (GENE)

Number of shares outstanding as of December 2024 : 3,379,358